Answers are grounded in this paper and cite their sources.
We conducted a retrospective chart review of 12 patients treated with the modified Atkins diet (MAD) (10 of 12 patients) or low glycemic index treatment (LGIT) (2 of 12 patients) for idiopathic generalized epilepsy (IGE) at Texas Children's Hospital Epilepsy Clinic from January 2019 to December 2022. Epilepsy subtypes were childhood absence epilepsy (CAE) in 3 of 12 patients, juvenile absence epilepsy (JAE) in 5 of 12 patients, and juvenile myoclonic epilepsy (JME) in 4 of 12 patients. The median duration of dietary therapy was 28 months (IQR 24.0-42.0). One patient had inadequate dietary treatment trial. Five of 10 patients (50%) with an active seizure burden achieved seizure freedom, with overall 10 of 10 (100%) achieving ≥50% reduction in seizures. Follow-up EEGs normalized in 2 of 9 patients (22.2%) with interictal generalized epileptiform discharges in 3 of 9 (33.3%) patients. Seven of 11 patients (63.6%) eventually chose to discontinue the diet, some despite good compliance. MAD and LGIT diets, although effective in phenotypically severe IGE, have practical adherence challenges in pediatric patients.
No takes yet. Share an insight, caveat, or question.
Nath et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: